Success Metrics

Clinical Success Rate
85.4%

Based on 35 completed trials

Completion Rate
85%(35/41)
Active Trials
6(11%)
Results Posted
37%(13 trials)
Terminated
6(11%)

Phase Distribution

Ph phase_3
12
21%
Ph phase_1
8
14%
Ph early_phase_1
3
5%
Ph phase_2
10
18%
Ph phase_4
7
13%
Ph not_applicable
13
23%

Phase Distribution

11

Early Stage

10

Mid Stage

19

Late Stage

Phase Distribution53 total trials
Early Phase 1First-in-human
3(5.7%)
Phase 1Safety & dosage
8(15.1%)
Phase 2Efficacy & side effects
10(18.9%)
Phase 3Large-scale testing
12(22.6%)
Phase 4Post-market surveillance
7(13.2%)
N/ANon-phased studies
13(24.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

79.5%

35 of 44 finished

Non-Completion Rate

20.5%

9 ended early

Currently Active

6

trials recruiting

Total Trials

56

all time

Status Distribution
Active(6)
Completed(35)
Terminated(9)
Other(6)

Detailed Status

Completed35
Terminated6
Recruiting5
unknown5
Withdrawn3
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
56
Active
6
Success Rate
85.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (5.7%)
Phase 18 (15.1%)
Phase 210 (18.9%)
Phase 312 (22.6%)
Phase 47 (13.2%)
N/A13 (24.5%)

Trials by Status

withdrawn35%
suspended12%
completed3563%
recruiting59%
active_not_recruiting12%
terminated611%
unknown59%

Recent Activity

Clinical Trials (56)

Showing 20 of 56 trialsScroll for more
NCT03505736

Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer

Completed
NCT03537586Not Applicable

A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction

Active Not Recruiting
NCT06993038Phase 4

Adenosine vs Diltiazem for Treatment of SVT in the ED

Recruiting
NCT03218137Phase 4

Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular Contractions

Recruiting
NCT06578234Phase 4

Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses

Recruiting
NCT06717685Phase 3

Efficacy of Adenosine as Compared to Verapamil in Paroxysmal Supraventricular Tachycardia (pSVT) Patients

Recruiting
NCT04666454Phase 4

BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome.

Recruiting
NCT03557385Phase 4

Adenosine Contrast CorrELations in Evaluating RevAscularizaTION

Completed
NCT05014061Phase 3

Adenosine's Effect on STunning Resolution in Acute Myocardial Infarction

Withdrawn
NCT04588441Phase 2

The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19

Withdrawn
NCT04577443Not Applicable

The Effect of Adenosine on Cranial Hemodynamic, Headache and Migraine Induction Properties.

Completed
NCT03236311Phase 2

A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI

Terminated
NCT03738943Early Phase 1

Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults

Completed
NCT04392362Phase 3

A Trial to Compare American Heart Association (AHA) and Simple (SIM)Method to Give Adenosine to Treat Supra-ventricular Tachycardia (SVT)

Completed
NCT04699110Phase 4

Adrenaline for the Treatment of No-Reflow in Normotensive Patients

Completed
NCT04203368Not Applicable

Adenosine Versus Verapamil for Management of Supraventricular Tachycardia Post- Coronary Artery Bypass Grafting

Completed
NCT04600115Early Phase 1

New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)

Unknown
NCT03249272Phase 4

Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve

Terminated
NCT02608944Not Applicable

Comparison of Quantitative MRI Perfusion Methods With Quantitative PET Perfusion Imaging

Withdrawn
NCT00179010Phase 1

AMP as a Better Delivery System of Adenosine

Terminated

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
56